374 filings
Page 4 of 19
SC 13G/A
ds5b7
14 Feb 23
BioNTech SE / ATHOS KG ownership change
6:06am
S-8
at2nzafw6lujlf
13 Feb 23
Registration of securities for employees
5:06pm
S-8 POS
uzbj cfqlm6
13 Feb 23
Registration of securities for employees (post-effective amendment)
4:04pm
6-K
zoi ky3atesq
10 Jan 23
Current report (foreign)
4:04pm
6-K
go3 mq9145yujd
10 Jan 23
BioNTech to Acquire InstaDeep to Strengthen Pioneering Position in the Field of AI-powered Drug Discovery, Design and Development
9:07am
6-K
1xapu30sc ub
22 Dec 22
BioNTech and Fosun Pharma Provide COVID-19 Vaccine Doses For Vaccination of German Expatriates in China
8:03am
6-K
olceyb0hg0 y2t
9 Dec 22
Pfizer and BioNTech Receive U.S. FDA Fast Track Designation
9:17am
6-K
898uuro fxqq
8 Dec 22
Pfizer and BioNTech Receive U.S. FDA Emergency Use Authorization for Omicron BA.4/BA.5-Adapted Bivalent COVID-19 Vaccine in Children Under 5 Years
5:27pm
6-K
sxu40hw9963qow 5e4e
7 Dec 22
Current report (foreign)
5:39pm
6-K
vxa6h6zo8cft6beb
5 Dec 22
Current report (foreign)
8:48am
6-K
kxqstu
30 Nov 22
BioNTech and Ryvu Therapeutics Enter into Global Collaboration to Develop and Commercialize Immuno-Modulatory Small Molecule Candidates
7:51am
6-K
8zu8473pumowhgo
18 Nov 22
Current report (foreign)
7:43am
6-K
92ird
16 Nov 22
Current report (foreign)
9:56pm
6-K
dwqueqmk r8jan
10 Nov 22
Pfizer and BioNTech Receive Positive CHMP Opinion for Omicron BA.4/BA.5-Adapted Bivalent COVID-19 Vaccine Booster
4:33pm
6-K
4hvclt1xm7
10 Nov 22
Current report (foreign)
4:32pm
6-K
uc23 ghbwu
7 Nov 22
Unaudited Interim Condensed Consolidated Financial Statements
6:24am
6-K
w00dpm1wfv1br3r
7 Nov 22
BioNTech Announces Third Quarter 2022 Financial Results and Corporate Update
6:07am
6-K
kxcqx6m1u hfq46h
4 Nov 22
Current report (foreign)
5:00pm
20-F/A
l5yrr1k5r1h0h e7u
26 Oct 22
Annual report (foreign) (amended)
5:20pm
6-K
p1e 2gvowzk0anwkx
19 Oct 22
Current report (foreign)
6:27pm